Siegel Rare Neuroimmune Association
EIN: 911780467 · Powell, OH · NTEE: G99
Is Siegel Rare Neuroimmune Association Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Siegel Rare Neuroimmune Association
Siegel Rare Neuroimmune Association (EIN: 911780467) is a nonprofit organization based in Powell, OH, classified under NTEE code G99. The organization reported total revenue of $1.5M and total assets of $1.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Siegel Rare Neuroimmune Association's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Siegel Rare Neuroimmune Association is a mid-size nonprofit that has been operating for 29 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 20.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.3M |
| Total Expenses | $1.2M |
| Surplus / Deficit | +$45K |
| Total Assets | $1.7M |
| Total Liabilities | $128K |
| Net Assets | $1.6M |
| Operating Margin | 3.5% |
| Debt-to-Asset Ratio | 7.4% |
| Months of Reserves | 16.9 months |
Financial Health Grade: A
In 2023, Siegel Rare Neuroimmune Association reported a surplus of $45K with revenue exceeding expenses, holds 16.9 months of operating reserves (strong position), has a debt-to-asset ratio of 7.4% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Siegel Rare Neuroimmune Association's revenue has grown at a compound annual growth rate (CAGR) of 20.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +4.3% | +11.8% | +5.3% |
| 2022 | -14.0% | +60.5% | +6.3% |
| 2021 | +88.3% | +18.4% | +98.1% |
| 2020 | -17.1% | -40.3% | +15.1% |
| 2019 | +14.4% | +34.7% | -3.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1997 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Siegel Rare Neuroimmune Association has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Siegel Rare Neuroimmune Association with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $45K, with revenue exceeding expenses.
- Debt-to-asset ratio: 7.4%.
Frequently Asked Questions about Siegel Rare Neuroimmune Association
Is Siegel Rare Neuroimmune Association a legitimate charity?
Based on AI analysis of IRS 990 filings, Siegel Rare Neuroimmune Association (EIN: 911780467) insufficient data. 0 red flags identified, 0 strengths noted.
How does Siegel Rare Neuroimmune Association spend its money?
Detailed spending breakdown data is not yet available for Siegel Rare Neuroimmune Association. Check back for updated IRS 990 analysis.
Are donations to Siegel Rare Neuroimmune Association tax-deductible?
Siegel Rare Neuroimmune Association is registered as a tax-exempt nonprofit (EIN: 911780467). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Filing History
IRS 990 filing history for Siegel Rare Neuroimmune Association showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Siegel Rare Neuroimmune Association's revenue has grown by 818.4%, moving from $138K to $1.3M. Total assets increased by 160.5% over the same period, from $661K to $1.7M. Total functional expenses rose by 924.9%, from $120K to $1.2M. In its most recent filing year (2023), Siegel Rare Neuroimmune Association reported a surplus of $45K, with revenue exceeding expenses. The organization holds $128K in liabilities against $1.7M in assets (debt-to-asset ratio: 7.4%), resulting in net assets of $1.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.3M | $1.2M | $1.7M | $128K | — | — |
| 2022 | $1.2M | $1.1M | $1.6M | $86K | — | — |
| 2021 | $1.4M | $683K | $1.5M | $111K | — | View 990 |
| 2020 | $752K | $577K | $777K | $81K | — | View 990 |
| 2019 | $907K | $966K | $675K | $155K | — | View 990 |
| 2018 | $792K | $717K | $700K | $120K | — | View 990 |
| 2017 | $692K | $878K | $612K | $108K | — | View 990 |
| 2016 | $530K | $683K | $748K | $58K | — | View 990 |
| 2015 | $613K | $480K | $898K | $54K | — | View 990 |
| 2014 | $619K | $436K | $740K | $29K | — | View 990 |
| 2013 | $396K | $446K | $546K | $18K | — | View 990 |
| 2012 | $206K | $289K | $581K | $3K | — | View 990 |
| 2011 | $138K | $120K | $661K | $733 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.3M, expenses of $1.2M, and assets of $1.7M (revenue +4.3% year-over-year).
- 2022: Revenue of $1.2M, expenses of $1.1M, and assets of $1.6M (revenue -14.0% year-over-year).
- 2021: Revenue of $1.4M, expenses of $683K, and assets of $1.5M (revenue +88.3% year-over-year).
- 2020: Revenue of $752K, expenses of $577K, and assets of $777K (revenue -17.1% year-over-year).
- 2019: Revenue of $907K, expenses of $966K, and assets of $675K (revenue +14.4% year-over-year).
- 2018: Revenue of $792K, expenses of $717K, and assets of $700K (revenue +14.5% year-over-year).
- 2017: Revenue of $692K, expenses of $878K, and assets of $612K (revenue +30.7% year-over-year).
- 2016: Revenue of $530K, expenses of $683K, and assets of $748K (revenue -13.7% year-over-year).
- 2015: Revenue of $613K, expenses of $480K, and assets of $898K (revenue -0.9% year-over-year).
- 2014: Revenue of $619K, expenses of $436K, and assets of $740K (revenue +56.2% year-over-year).
- 2013: Revenue of $396K, expenses of $446K, and assets of $546K (revenue +92.4% year-over-year).
- 2012: Revenue of $206K, expenses of $289K, and assets of $581K (revenue +48.9% year-over-year).
- 2011: Revenue of $138K, expenses of $120K, and assets of $661K.
Data Sources and Methodology
This transparency report for Siegel Rare Neuroimmune Association is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.